Incannex Healthcare (IXHL) Competitors $0.61 +0.24 (+64.82%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$0.63 +0.02 (+2.95%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. DARE, NRSN, MIRA, NNVC, FBLG, TPST, ALXO, QTTB, CVKD, and TENXShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Dare Bioscience (DARE), NeuroSense Therapeutics (NRSN), MIRA Pharmaceuticals (MIRA), NanoViricides (NNVC), FibroBiologics (FBLG), Tempest Therapeutics (TPST), ALX Oncology (ALXO), Q32 Bio (QTTB), Cadrenal Therapeutics (CVKD), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Its Competitors Dare Bioscience NeuroSense Therapeutics MIRA Pharmaceuticals NanoViricides FibroBiologics Tempest Therapeutics ALX Oncology Q32 Bio Cadrenal Therapeutics Tenax Therapeutics Dare Bioscience (NASDAQ:DARE) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends. Which has higher valuation & earnings, DARE or IXHL? Dare Bioscience is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDare Bioscience$10K2,230.20-$4.05M-$0.17-14.82Incannex Healthcare$10K1,795.23-$18.46M-$1.21-0.50 Is DARE or IXHL more profitable? Dare Bioscience's return on equity of 0.00% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Dare BioscienceN/A N/A -8.14% Incannex Healthcare N/A -342.92%-148.64% Do analysts rate DARE or IXHL? Dare Bioscience presently has a consensus target price of $12.00, suggesting a potential upside of 376.19%. Given Dare Bioscience's stronger consensus rating and higher probable upside, analysts clearly believe Dare Bioscience is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dare Bioscience 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Incannex Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in DARE or IXHL? 6.7% of Dare Bioscience shares are held by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are held by institutional investors. 4.0% of Dare Bioscience shares are held by insiders. Comparatively, 15.5% of Incannex Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer DARE or IXHL? In the previous week, Dare Bioscience and Dare Bioscience both had 5 articles in the media. Dare Bioscience's average media sentiment score of 0.82 beat Incannex Healthcare's score of 0.00 indicating that Dare Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dare Bioscience 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Incannex Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, DARE or IXHL? Dare Bioscience has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.47, meaning that its share price is 647% more volatile than the S&P 500. SummaryDare Bioscience beats Incannex Healthcare on 10 of the 13 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IXHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.95M$2.44B$5.53B$9.42BDividend YieldN/A1.80%3.76%4.04%P/E Ratio-0.509.0228.2619.78Price / Sales1,795.23535.66414.9388.57Price / CashN/A161.4735.8558.18Price / Book3.395.008.115.65Net Income-$18.46M$30.99M$3.25B$257.97M7 Day Performance176.90%1.69%1.63%3.74%1 Month Performance178.41%10.07%7.62%11.95%1 Year Performance-72.89%0.90%32.74%19.22% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.413 of 5 stars$0.61+64.8%N/A-72.9%$17.95M$10K-0.503News CoverageAnalyst UpgradeGap UpHigh Trading VolumeDAREDare Bioscience2.0343 of 5 stars$3.09+22.6%$12.00+288.3%-28.8%$27.35M$10K-18.1830Gap UpHigh Trading VolumeNRSNNeuroSense Therapeutics2.1224 of 5 stars$2.00-3.4%$14.00+600.0%+180.3%$27.33MN/A-3.7010MIRAMIRA Pharmaceuticals1.8365 of 5 stars$1.54+20.3%$14.00+809.1%+161.3%$26.06MN/A-3.022High Trading VolumeNNVCNanoViricides0.4398 of 5 stars$1.60+14.7%N/A-20.4%$25.72MN/A-2.2220High Trading VolumeFBLGFibroBiologics3.2558 of 5 stars$0.64+1.7%$13.00+1,931.3%-85.1%$25.40MN/A-3.0510TPSTTempest Therapeutics1.6236 of 5 stars$6.90-0.7%$30.00+334.8%-74.9%$25.39MN/A-0.3820Positive NewsALXOALX Oncology3.1655 of 5 stars$0.47-2.8%$3.30+603.9%-91.8%$25.03MN/A-0.1940Gap DownQTTBQ32 Bio2.1668 of 5 stars$2.03-23.7%$12.17+499.3%-92.6%$24.77M$1.16M-0.4139Analyst DowngradeHigh Trading VolumeCVKDCadrenal Therapeutics2.2082 of 5 stars$12.50-3.3%$32.00+156.0%N/A$24.59MN/A-1.354Positive NewsTENXTenax Therapeutics1.2737 of 5 stars$5.90+1.7%$17.50+196.6%+74.3%$24.47MN/A-2.389Positive News Related Companies and Tools Related Companies Dare Bioscience Alternatives NeuroSense Therapeutics Alternatives MIRA Pharmaceuticals Alternatives NanoViricides Alternatives FibroBiologics Alternatives Tempest Therapeutics Alternatives ALX Oncology Alternatives Q32 Bio Alternatives Cadrenal Therapeutics Alternatives Tenax Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IXHL Stock Alerts